Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Liabilities and Shareholders Equity (2020 - 2025)

Celularity (CELU) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $114.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 11.33% to $114.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $496.1 million, a 10.14% decrease, with the full-year FY2024 number at $132.7 million, down 7.79% from a year prior.
  • Liabilities and Shareholders Equity was $114.2 million for Q3 2025 at Celularity, down from $120.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $448.3 million in Q3 2021 to a low of $114.2 million in Q3 2025.
  • A 5-year average of $252.6 million and a median of $157.2 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 234.33% in 2022, then crashed 64.12% in 2023.
  • Celularity's Liabilities and Shareholders Equity stood at $414.1 million in 2021, then dropped by 3.15% to $401.1 million in 2022, then plummeted by 64.12% to $143.9 million in 2023, then decreased by 7.79% to $132.7 million in 2024, then dropped by 13.9% to $114.2 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Liabilities and Shareholders Equity are $114.2 million (Q3 2025), $120.3 million (Q2 2025), and $128.9 million (Q1 2025).